rs786202259
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1_ModeratePM2PP5_Very_Strong
The NM_005732.4(RAD50):c.3779delG(p.Arg1260LeufsTer7) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000342 in 1,461,778 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_005732.4 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RAD50 | NM_005732.4 | c.3779delG | p.Arg1260LeufsTer7 | frameshift_variant | Exon 25 of 25 | ENST00000378823.8 | NP_005723.2 | |
TH2LCRR | NR_132125.1 | n.183delC | non_coding_transcript_exon_variant | Exon 2 of 3 | ||||
TH2LCRR | NR_132126.1 | n.175-3939delC | intron_variant | Intron 1 of 1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RAD50 | ENST00000378823.8 | c.3779delG | p.Arg1260LeufsTer7 | frameshift_variant | Exon 25 of 25 | 1 | NM_005732.4 | ENSP00000368100.4 | ||
ENSG00000283782 | ENST00000640655.2 | c.3482delG | p.Arg1161LeufsTer7 | frameshift_variant | Exon 26 of 26 | 5 | ENSP00000491596.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251302Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135810
GnomAD4 exome AF: 0.00000342 AC: 5AN: 1461778Hom.: 0 Cov.: 31 AF XY: 0.00000275 AC XY: 2AN XY: 727204
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Hereditary cancer-predisposing syndrome Pathogenic:2
The c.3779delG pathogenic mutation, located in coding exon 25 of the RAD50 gene, results from a deletion of one nucleotide at nucleotide position 3779, causing a translational frameshift with a predicted alternate stop codon (p.R1260Lfs*7). This frameshift occurs at the 3' terminus of RAD50 and is not expected to trigger nonsense-mediated mRNA decay, however it is expected to produce an abnormal protein lacking a portion of the C-terminal that is an important ATPase domain (Williams GJ et al. DNA Repair (Amst.), 2010 Dec;9:1299-306). This alteration is expected to result in loss of function by premature protein truncation. As such, this alteration is interpreted as a disease-causing mutation. -
This sequence change creates a premature translational stop signal (p.Arg1260Leufs*7) in the RAD50 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 53 amino acid(s) of the RAD50 protein. This variant is present in population databases (rs786202259, gnomAD 0.0009%). This premature translational stop signal has been observed in individual(s) with renal cancer (PMID: 26689913). ClinVar contains an entry for this variant (Variation ID: 185537). This variant disrupts the ATPase-C domain, which is important for RAD50 ATPase activity (PMID: 10892749, 24894818). While functional studies have not been performed to directly test the effect of this variant on RAD50 protein function, this suggests that disruption of this region of the protein is causative of disease. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at